Live
- People will not forgive Congress for repeatedly insulting Constitution: Kiren Rijiju
- Aid group resumes activities at famine-hit camp in Sudan
- Kishan Reddy Vows to End BRS and Congress Influence in Telangana, Criticizes CM's Governance
- Punjab bypolls: Bittu twisting words for political gains, says Congress nominee
- Punjab CM to administer oath to over 10,000 sarpanches on Friday
- BJP Core Committee Plans Protests Against State Government’s Failures
- Mulugu Collector Divakar's Facebook Hacked Again, Cyber Criminals Send Fraudulent Messages Asking for Money
- The Role of Genetics in Obesity: Can Metabolic Bariatric Surgery Help?
- Deputy CM Bhatti Vikramarka's Visit to Khammam District: Lays Foundation for Road Works Worth Rs. 8.9 Crore
- ED Files Charge Sheet in Agrigold Case, Attaches Assets Worth Over ₹4,100 Crores
Oxford University Covid-19 vaccine tested on 6 monkeys
An experimental vaccine developed by researchers at Oxford University has shown promise in preventing COVID-19, according to a small trial in six monkeys
London: An experimental vaccine developed by researchers at Oxford University has shown promise in preventing COVID-19, according to a small trial in six monkeys.
The vaccine candidate, ChAdOx1 nCoV-19, is currently being tested in humans too. Over 1,000 volunteers have participated in the clinical trials.
The results of the trial in six rhesus macaque monkeys were posted on Thursday at the preprint repository bioRxiv.
Rhesus macaque monkeys are considered to be good proxies for how drugs could work in humans as their immune systems are similar, but there is not guarantee that the results would replicate in people.
The researchers found that compared to those monkeys who got exposed to the virus that causes COVID-19 but did not receive the vaccine, the monkeys which received the vaccine had less of the virus in their lungs and airways.
The results showed that the ChAdOx1 nCoV-19 vaccination appears to prevent SARS-CoV-2 pneumonia in rhesus macaques.
Researchers from the US government's National Institutes of Health (NIH) and from the University of Oxford conducted the trial in the US, the BBC reported.
The researchers at Oxford University who have begun testing their potential vaccine against COVID-19 on a small group of human volunteers also hope to expand the tests soon after getting positive results from the initial trial.
